Evidence map›Paper›PMID 21124939›Full record

ArticlePLoS pathogens2010

Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.

Rahul Mittal, Sunil K Sukumaran, Suresh K Selvaraj, David G Wooster, M Madan Babu, Alan D Schreiber, J Sjef Verbeek, Nemani V Prasadarao

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Specific interaction between Group BInfection and immunity · 2024
    Article
  4. Lyme Disease Agent ReservoirsPathogens (Basel, Switzerland) · 2023
    Article
  5. Macrophage polarization duringFrontiers in microbiology · 2023
    Article
  6. Article
  7. Nucleotide receptors mediate protection against neonatal sepsis and meningitis caused by alpha-hemolysin expressing Escherichia coli K1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  8. Frontiers in pharmacology · 2022
    Article
  9. Modulation Effects ofVaccines · 2020
    Article
  10. THE EXPOSOME IN HUMAN EVOLUTION: FROM DUST TO DIESEL.The Quarterly review of biology · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction.Translational research : the journal of laboratory and clinical medicine · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Rahul MittalThe Saban Research Institute, Childrens Hospital, Los Angeles, CA, USA.
Sunil K Sukumaran
Suresh K Selvaraj
David G Wooster
M Madan Babu
Alan D Schreiber
J Sjef Verbeek
Nemani V Prasadarao
Children's Hospital of Los Angeles · USLeiden University Medical Center · NLMedical Research Council · GBUniversity of Pennsylvania · US

Funding

Brain Endothelial Receptor for E. coliR01AI040567 · NIAID · CHILDREN'S HOSPITAL OF LOS ANGELES · PI DAVIS, MARK E, GODDARD, WILLIAM ANDREW · 2001 to 2015
$5.5M
Maneuvering of Macrophage Function By Escherichia coli K1R01NS073115 · NINDS · CHILDREN'S HOSPITAL OF LOS ANGELES · PI NEMANI, PRASADARAO V · 2010 to 2014
$1.6M
BRAIN ENDOTHELIAL GLYCOPROTEIN INTERACTIVE WITH E COLIR29AI040567 · NIAID · CHILDREN'S HOSPITAL LOS ANGELES · PI NEMANI, PRASADARAO V · 1997 to 2001
$211k
Medical Research Council MC_U105185859NIAID NIH HHS AI40567NIAID NIH HHS R01 AI040567NIAID NIH HHS R29 AI040567NINDS NIH HHS NS73115NINDS NIH HHS R01 NS073115
6 · The paper itself

Abstract

Neonatal meningitis due to Escherichia coli K1 is a serious illness with unchanged morbidity and mortality rates for the last few decades. The lack of a comprehensive understanding of the mechanisms involved in the development of meningitis contributes to this poor outcome. Here, we demonstrate that depletion of macrophages in newborn mice renders the animals resistant to E. coli K1 induced meningitis. The entry of E. coli K1 into macrophages requires the interaction of outer membrane protein A (OmpA) of E. coli K1 with the alpha chain of Fcγ receptor I (FcγRIa, CD64) for which IgG opsonization is not necessary. Overexpression of full-length but not C-terminal truncated FcγRIa in COS-1 cells permits E. coli K1 to enter the cells. Moreover, OmpA binding to FcγRIa prevents the recruitment of the γ-chain and induces a different pattern of tyrosine phosphorylation of macrophage proteins compared to IgG2a induced phosphorylation. Of note, FcγRIa(-/-) mice are resistant to E. coli infection due to accelerated clearance of bacteria from circulation, which in turn was the result of increased expression of CR3 on macrophages. Reintroduction of human FcγRIa in mouse FcγRIa(-/-) macrophages in vitro increased bacterial survival by suppressing the expression of CR3. Adoptive transfer of wild type macrophages into FcγRIa(-/-) mice restored susceptibility to E. coli infection. Together, these results show that the interaction of FcγRI alpha chain with OmpA plays a key role in the development of neonatal meningitis by E. coli K1.

Indexed as

AnimalsAnimals, NewbornBacterial Outer Membrane ProteinsBinding, CompetitiveBlotting, WesternBrainChlorocebus aethiopsCOS CellsEscherichia coliFlow CytometryHumansImmunoglobulin GImmunoprecipitationMacrophage-1 AntigenMacrophagesMeningitis, Escherichia coliBacterial Outer Membrane ProteinsImmunoglobulin GMacrophage-1 AntigenNitric OxideOMPA outer membrane proteinsReceptors, IgGRNA, Messenger

Identifiers

PMID21124939
PMCPMC2987830
OpenAlexW2112270200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.